Today: 16 April 2026
Subscribe
Browse Category

NASDAQ:AIFF 5 March 2026

Firefly Neuroscience stock jumps 126% after Nvidia GPU push and 33-fold brain-scan surge

Firefly Neuroscience stock jumps 126% after Nvidia GPU push and 33-fold brain-scan surge

Firefly Neuroscience reported a 33-fold jump in EEG/ERP brain scan volumes to over 10,800 in 2025 and expanded to 99 commercial users, up more than 20-fold. The company is deploying NVIDIA L40S GPUs to accelerate processing for a new AI “foundation model” built on EEG data. Shares closed at $1.55, up 126% in 24 hours. Growth followed the acquisition of Evoke Neuroscience and internal initiatives.
5 March 2026
··

Stock Market Today

  • Snap Shares Surge 7.7% After Announcing 1,000 Job Cuts and $500M Savings Plan
    April 15, 2026, 6:18 PM EDT. Snap's stock jumped 7.68% to $6.03 following its announcement of a 16% workforce reduction, cutting around 1,000 jobs, targeting over $500 million in annual cost savings. The social media company outlined a shift toward an AI-driven strategy amid ongoing unprofitability since its 2017 IPO. Trading volume spiked to 143.9 million shares, 161% above the three-month average. Despite these changes, stock-based compensation remains high at 17% of sales, challenging profitability prospects. The S&P 500 and Nasdaq also rose, supported by gains in Meta and Pinterest, highlighting broader digital sector strength. Investors should weigh Snap's potential turnaround against its historical struggles and shareholder dilution risks.

Latest article

Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

16 April 2026
China is considering export restrictions on advanced solar-manufacturing equipment to the U.S., potentially affecting Tesla’s plans for new factories, sources told Reuters. Tesla aims to buy $2.9 billion in solar-panel equipment from China and expand U.S. solar production. China produces over 80% of global solar panel components. No final decision has been made, and consultations remain preliminary.
Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

15 April 2026
Hims & Hers Health shares rose 14% to $24.29 after the FDA said it will review restrictions on several peptides, including BPC-157 and TB-500. The agency set a July advisory meeting and will remove some peptides from its safety-risk list within a week. Hims, which acquired a California peptide facility last year, reported $2.35 billion in 2025 revenue and 2.511 million subscribers.
Strategy (MSTR) Buys $1 Billion More Bitcoin as STRC Funding Pushes Holdings Near 800,000 BTC

Strategy (MSTR) Buys $1 Billion More Bitcoin as STRC Funding Pushes Holdings Near 800,000 BTC

15 April 2026
Strategy bought 13,927 bitcoin for about $1 billion last week, funding the purchase entirely with sales of its STRC preferred stock, according to an April 13 filing. The company now holds 780,897 BTC, bought at an average $71,902 each. No common stock was sold during the period. STRC volume rose to 15.7 million shares on April 14, trading near $100 ahead of the April 15 dividend record date.
Go toTop